Lactoferricin vs Pexiganan — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Lactoferricin B (LfcinB) is a 25-residue antimicrobial peptide released from the N-terminal region of bovine lactoferrin by pepsin digestion in the stomach. The core hexapeptide RRWQWR contains the minimal active unit....
Calculate Lactoferricin dose →Pexiganan (MSI-78) is a synthetic analog of magainin-2, optimized for enhanced broad-spectrum antimicrobial activity and reduced hemolytic toxicity. It was developed by Magainin Pharmaceuticals (later Genaera) as a topical treatment for mildly infected diabetic foot ulcers....
Calculate Pexiganan dose →| Parameter | Lactoferricin | Pexiganan |
|---|---|---|
| Category | Antimicrobial Peptide | Antimicrobial Peptide |
| Research | Preclinical | Phase 3 (Failed 1999) |
| Half-Life | Minutes (proteolytic) | Hours (topical) |
| Typical Dose | N/A | 0.8% cream topically |
| Frequency | N/A | Twice daily |
| Route | Research only | Topical cream |
| FDA Status | Not approved | Not approved (failed Phase 3) |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.